USE OF PYRAZOLE-PYRIDINE DERIVATIVES AND ITS SALTS FOR TREATING OR REVENTIN OSTEOPOROSIS

摘要

The present invention provides a pharmaceutical composition comprising a pyrazole-pyridine derivative or a pharmaceutically allowable salt thereof for preventing or treating osteoporosis, and particularly relates to a use of a pyrazole-pyridine derivative or a salt thereof that has a bone formation activity by promoting differentiation from a mesenchymal stem cells into osteoblast cells as a preventing or treating agent of bone metabolism diseases, in particular, osteoporosis. The present invention relates to a use of a pyrazole-pyridine derivative or a pharmaceutically allowable salt thereof as an agent for preventing or treating osteoporosis, and the present invention is capable of being used in various diseases that relates to a bone metabolism such as regeneration of the alveolar bone, osteogenesis imperfecta, osteomalacia and the like in addition to prevention or curing effect of osteoporosis.